Treatment of Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
- Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, et al. Treatment of drug-resistant tuberculosis. an official ATS/CDC/ERS/IDSA clinical practice guideline. Am J Respir Crit Care Med 2019; 200(10):e93-e142.
- Editorials and Letters to the Editor
- Chang K and Yew W. ATS/CDC/ERS/IDSA clinical practice guidelines for treatment of drug-resistant TB: a two-edged sword?. Am J Respir Crit Care Med 2020 (In Press)
- Sotgiu G, Migliori GB, Menzies D, Mase S, Chorba T, Seaworth B, et al. Reply to: “ATS/CDC/ERS/IDSA clinical practice guidelines for treatment of drug-resistant TB: a two-edged sword?". Am J Respir Crit Care Med 2020 (In Press)
- ECRI Institute Guideline Summary and Scorecard
- Pre-registration required for free access.
- Press Release
- Guideline Central Pocket Guide
- Podcast
Complementary Materials
- Other Related Guidelines
- Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, et al. Official ATS/IDSA/CDC clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clinical Infectious Diseases 2017;64(2):e1–e33.
- Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official ATS/IDSA/CDC clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clinical Infectious Diseases 2016;63(7):853–67
- Related CME
- Related Editorials and Letters to the Editor
- Andres S, Merker M, Heyckendorf J, Kalsdorf B, Rumetshofer R, Indra A, et al. Bedaquiline-resistant tuberculosis: dark clouds on the horizon. Am J Respir Crit Care Med 2020; 201(12):1564-1568.
- de Jager VR, Vanker N, van der Merwe L, van Brakel E, Muliaditan M, Diacon AH. Optimizing β-Lactams against tuberculosis. Am J Respir Crit Care Med 2020; 201(9):1155-1157.
- Nathavitharana RR. Stamping out tuberculosis: the importance of diagnostic innovation and effective implementation. Ann Am Thorac Soc 2019; 16(9):1112-1113.
- Kranzer K, Kalsdorf B, Heyckendorf J, Andres S, Merker M, Hofmann-Thiel S, et al. New WHO treatment recommendations for multidrug-resistant tuberculosis: are we well enough prepared?. Am J Respir Crit Care Med 2019; 200(4):514-515.
- Schluger NW. Tuberculosis elimination, research, and respect for persons. Am J Respir Crit Care Med 2019; 199(5):560-563.
- Keshavjee S, Amanullah F, Cattamanchi A, Chaisson R, Dobos KM, Fox GJ, et al. Moving toward tuberculosis elimination. critical issues for research in diagnostics and therapeutics for tuberculosis infection. Am J Respir Crit Care Med 2019; 199(5):564–571.
- General Reviews and Updates
- Wilson JW, Nilsen DM, Marks SM. Multidrug resistant tuberculosis in patients with HIV: management considerations within high-resourced settings. Ann Am Thorac Soc 2020; 17(1):16-23.
- Niederman MS, Nair GB, Matt U, Herold S, Pennington K, Crothers K, et al. Update in lung infections and tuberculosis 2018. Am J Respir Crit Care Med 2019; 200(4):414–422.
- Gunther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, et al. Clinical management of multidrug-resistant tuberculosis in 16 european countries. Am J Respir Crit Care Med 2018; 198(3):379–386.
- Abubakar I, Gupta RK, Rangaka MX, Lipman M. Update in tuberculosis and nontuberculous mycobacteria 2017. Am J Respir Crit Care Med 2018; 197(10):1248–1253.
- Related Scientific Symposia
- Related Press Releases
- FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis (Aug. 14, 2019) - TB Alliance
- FDA Advisory Committee Votes Favorably on the Question of the Effectiveness and Safety of Pretomanid in Combination with Bedaquiline and Linezolid for Treatment of Highly Drug-Resistant Forms of Tuberculosis (Jun. 6, 2019) - TB Alliance
- Related Public Health Interest Materials
- Tuberculosis (2017)
- Related Webinars
- The Emergence and Spread of MDR TB (Nov. 23, 2015) - Presenter: Theodore Cohen, DPH, MD, MPH and Peter Cegielski, MD
- Toward a shorter and simpler treatment of TB: Are we there yet? (Feb. 12, 2015) - Presenter: Digby Warner, Ph.D. and Stephen H Gillespie MD DSc FRCP FRCPath
